中国中医基础医学杂志
中國中醫基礎醫學雜誌
중국중의기출의학잡지
CHINESE JOURNAL OF BASIC MEDICINE IN ADITIONAL CHINESE MEDICINE
2001年
3期
59-61
,共3页
冠心病%单核细胞%凝血/纤溶活性中医证型
冠心病%單覈細胞%凝血/纖溶活性中醫證型
관심병%단핵세포%응혈/섬용활성중의증형
目的: 研究冠心病患者单核细胞凝血/纤溶活性改变与中医辨证分型的关系。方法: 80例冠心病患者分为血瘀证组30例,痰浊证组27例,气滞证组23例,另设健康对照组20例;采用发色底物法分别检测外周血单核细胞(PBMC)促凝活性(PCA)、组织型纤溶酶原激活物(t-PA)及其抑制物(PAI-1)活性。结果:冠心病各组与健康对照组比较,PBMC PCA、PAI-1表达均显著升高,而t-PA表达显著下降(P<0.01);血瘀证与非血瘀证组(痰浊与气滞组)之间PBMC t-PA、PCA表达有显著差异(P<0.01),而PAI-1表达无差异(P>0.05);痰浊证组与气滞证组之间各项指标未见差异(P>0.05)。结论:冠心病患者单核细胞凝血/纤溶活性改变与中医辨证分型之间有一定的相关性,PBMC PCA增高和t-PA降低的程度对区别血瘀证和非血瘀证具有意义,血瘀证患者处于明显的血栓前状态。
目的: 研究冠心病患者單覈細胞凝血/纖溶活性改變與中醫辨證分型的關繫。方法: 80例冠心病患者分為血瘀證組30例,痰濁證組27例,氣滯證組23例,另設健康對照組20例;採用髮色底物法分彆檢測外週血單覈細胞(PBMC)促凝活性(PCA)、組織型纖溶酶原激活物(t-PA)及其抑製物(PAI-1)活性。結果:冠心病各組與健康對照組比較,PBMC PCA、PAI-1錶達均顯著升高,而t-PA錶達顯著下降(P<0.01);血瘀證與非血瘀證組(痰濁與氣滯組)之間PBMC t-PA、PCA錶達有顯著差異(P<0.01),而PAI-1錶達無差異(P>0.05);痰濁證組與氣滯證組之間各項指標未見差異(P>0.05)。結論:冠心病患者單覈細胞凝血/纖溶活性改變與中醫辨證分型之間有一定的相關性,PBMC PCA增高和t-PA降低的程度對區彆血瘀證和非血瘀證具有意義,血瘀證患者處于明顯的血栓前狀態。
목적: 연구관심병환자단핵세포응혈/섬용활성개변여중의변증분형적관계。방법: 80례관심병환자분위혈어증조30례,담탁증조27례,기체증조23례,령설건강대조조20례;채용발색저물법분별검측외주혈단핵세포(PBMC)촉응활성(PCA)、조직형섬용매원격활물(t-PA)급기억제물(PAI-1)활성。결과:관심병각조여건강대조조비교,PBMC PCA、PAI-1표체균현저승고,이t-PA표체현저하강(P<0.01);혈어증여비혈어증조(담탁여기체조)지간PBMC t-PA、PCA표체유현저차이(P<0.01),이PAI-1표체무차이(P>0.05);담탁증조여기체증조지간각항지표미견차이(P>0.05)。결론:관심병환자단핵세포응혈/섬용활성개변여중의변증분형지간유일정적상관성,PBMC PCA증고화t-PA강저적정도대구별혈어증화비혈어증구유의의,혈어증환자처우명현적혈전전상태。
To study the relationship between changes of coagulant and fibrinolytic activity of human peripheral blood monocyte (PBMC) in coronary heart disease (CHD) patients and different syndrome-type of Traditional Chinese Medicine (TCM). Methods:80 patients with coronary heart disease were divided into three groups by syndrome differentiation. 30cases of blood stasis (BS), 27cases of phregm-damp(PD) and 23cases of Qi stagnation(QS). 20 healthy persons were enrolled as normal control group. Activity of tissue type plasminogen activator(t-PA) and its inhibitor (API-1) and procoagulant activity (PCA) of PBMC were measured by chromogenic substrate method respectively. Results: PAI-1 activity and PCA expression of PBMC in the CHD group were significantly higher while t-PA activity of PBMC was lower than those in the normal control group (P<0.01). PCA expression of PBMC in the BS group was significantly higher than that in PD and QS groups, PBMC t-PA expression in BS group was lower than that in PD and QS groups (P<0.01). No significant difference of PAI-1 activity of PBMC was found among BS、PD and QS groups (P>0.05). All param3eters were found no significant difference between PD and QS groups (P>0.05). Conclusions: There is a relationship between changes of coagulant and fibrinolytic activity of monocyte in coronary heart disease patients and different syndrome-type of TCM. The increasing level of PBMC PCA and reducing level of PBMC t-PA could be used as referential indices for differentiating BS and NBS(PD and QS). Patients of BS were in the notable prethrombotic state.